Periodic Reporting for period 2 - T2EVOLVE (Accelerating Development and Improving Access to CAR and TCR-engineered T cell therapy)

Engineered chimeric antigen receptor (CAR) and T-cell receptor (TCR) T-cells are a transformative new form of therapy that involves removing immune cells from patients with cancer, modifying them so that they are better able to find and fight cancer. A number of challenges...